Condensed Consolidated Statement of Stockholders' Deficit - 9 months ended Sep. 30, 2018 - USD ($)	Preferred Stock [Member]	Common Stock [Member]	Additional Paid-In Capital [Member]	Accumulated Deficit [Member]	Total
Balances at beginning at Dec. 31, 2017	$ 55	$ 64,437	$ 15,862,980	$ (19,811,052)	$ (3,883,580)
Balances at beginning (in shares) at Dec. 31, 2017	55,000	64,437,163
Increase decrease in Stockholders' Equity [Roll Forward]
Stock based compensation			141,686		141,686
Issuance of common stock in acquisition of CureDM Group Holdings, LLC		$ 25,000	1,225,000		1,250,000
Issuance of common stock in acquisition of CureDM Group Holdings, LLC (in shares)		25,000,000
Issuance of Series A Preferred Stock for cash	$ 28		274,972		275,000
Issuance of Series A Preferred Stock for cash (in shares)	27,500
Conversion of convertible note payable and accrued interest into common stock		$ 17,027	1,260,039		1,277,066
Conversion of convertible note payable and accrued interest into common stock (in shares)		17,027,544
Issuance of common stock in exchange for consulting services		$ 3,667	326,333		330,000
Issuance of common stock in exchange for consulting services (in shares)		3,666,666
Issuance of warrants to purchase capital stock in exchange for extension of note payable			21,121		21,121
Issuance of warrants to purchase capital stock in exchange for extension of note payable (in shares)
Reclassification of derivative liability			10,617		10,617
Net loss				(2,110,209)	(2,110,209)
Balances at end at Sep. 30, 2018	$ 83	$ 110,131	$ 19,122,748	$ (21,921,261)	$ (2,688,299)
Balances at end (in shares) at Sep. 30, 2018	82,500	110,131,373